Literature DB >> 33581597

Establishing the metabolic network of isoquinoline alkaloids from the Macleaya genus.

Zhixing Qing1, Fangqin Yan2, Peng Huang3, Jianguo Zeng4.   

Abstract

Metabolic networks can provide insight into the biosynthesis pathways of natural products present in plant-derived medicines. Here, we primarily established a highly efficient and targeted method for the systematic screening of isoquinoline alkaloids from the Macleaya genus. A total of 392 potential alkaloids were detected, 204 of which were further identified according to their tandem mass spectrometry (MS/MS) spectra and the characteristic fragmentation patterns of references. A metabolic network of isoquinoline alkaloids from the Macleaya genus was then constructed based on the structural relationships, metabolic level differences, and the isotopically labeled [ring-13C6]-tyrosine feeding experiments. New biosynthesis pathways for well-known alkaloids (berberine, sanguinarine, and chelerythrine) in the Macleaya genus were proposed on the basis of the established metabolic network. This work marks the first comprehensive study of the metabolic network of isoquinoline alkaloids in the Macleaya genus and provides a template for constructing the metabolic networks of other plant-derived medicines.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biosynthesis pathway; Isoquinoline alkaloid; Isotope labeling; Macleaya cordata; Macleaya microcarpa; Metabolic network; Papaveraceae; Structural identification

Year:  2021        PMID: 33581597     DOI: 10.1016/j.phytochem.2021.112696

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  1 in total

1.  Antidepressant-like activity, active components and related mechanism of Hemerocallis citrina Baroni extracts.

Authors:  Jinghong Liu; Tian Ye; Shuaiyong Yang; Xiaohong Zhong; Wei He; Mengtao Xu; Jinpeng Fang; Miao Deng; Ning Xu; Jianguo Zeng; Zhixing Qing
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.